Ellen Oyen
Maastricht, Netherlands
NCT Number: NCT05976061
This study evaluates the implementation of the General Practitioners guidelines 'Suspicious Skin Lesions' and investigated whether their publication and implementation has led to a reduction in the proportion of referrals of low-risk patients with actinic keratosis to secondary care, after publication of the General Practitioners guidelines and implementation activities.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
Maastricht, Netherlands
In the Dutch healthcare system, patients are first examined by the general practitioner who decides whether a referral to a dermatologist is indicated. Both general practitioners and dermatologists can diagnose and treat patients with actinic keratosis. Therefore, it is necessary to distinguish which patients the general practitioner should refer to a dermatologist and which patients are suitable to be treated by the general practitioner.
This retrospective data study evaluates the proportion of low risk actinic keratosis patients in 2019 en 2018.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2018 compared to 2019 (2 years)
The change in proportion of low-risk actinic keratosis patients among all actinic keratosis patients referred by the general practitioner to the dermatologist. The definition of low-risk actinic keratosis patients was based on the General Practitioners guidelines 'Suspicious skin lesions' (published in 2017). Patients were defined as low-risk when they were not immunocompromised, did not have a cutaneous malignancy in their medical history, did not have previous treatment or if they did not have extensive lesions.
Maastricht University Medical Center
Other
High- and Low-risk Actinic Keratosis Referrals to Secondary Care. Implementation of the General Practitioners Guidelines for Actinic Keratosis Patients.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05987553
Actinic Keratoses, Dermatology
Maastricht, Netherlands
View Trial DetailsNCT06008171
Actinic Keratoses, Keratosis
Maastricht, Netherlands
View Trial DetailsNCT05976048
Actinic Keratoses, Keratosis
Maastricht, Netherlands
View Trial DetailsNCT05202860
Actinic Keratoses, Basal Cell Carcinoma
Copenhagen, Capital Region, Denmark
View Trial Details